FINGOLIMOD MYLAN 0.5 mg, hard capsule 28 capsules
Active ingredients: Fingolimod hydrochloride, Fingolimod
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule28 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FINGOLIMOD MYLAN 0,5 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium avec calendrier de 28 gélule(s)
- Marketing authorisation holder
- MYLAN PHARMACEUTICALS (IRLANDE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Apr 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64520985CIP73023652CIP133400930236529Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FINGOLIMODgélule | 0,5 mg · une gélule | FT |
| CHLORHYDRATE DE FINGOLIMODgélule | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.